Diabetes endocrine
Searched over 200M research papers for "diabetes endocrine"
Summary
10 papers analyzed
These studies suggest that endocrine-disrupting chemicals may increase the risk of type 2 diabetes, effective treatments include continuous insulin infusion and glucose monitoring, and advancements like endocrine system on chip and stem cell therapy offer potential in diabetes management.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
The Intersection of Endocrinology and Diabetes: Key Insights
Endocrine-Disrupting Chemicals and Type 2 Diabetes Risk
Endocrine-disrupting chemicals (EDCs) have been increasingly linked to the risk of developing type 2 diabetes (T2D). Elevated concentrations of EDCs in blood or urine are associated with a higher risk of T2D and related metabolic traits. These chemicals, such as dioxins, pesticides, and bisphenol A, can induce insulin resistance and disrupt pancreatic β-cell function, contributing to the etiology of T2D. EDCs mimic or block hormonal responses, often acting as estrogens in insulin-sensitive tissues, leading to a metabolic state similar to pregnancy, characterized by insulin resistance and hyperinsulinemia.
Diabetes Technology: Continuous Glucose Monitoring and Insulin Infusion
The use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) has become crucial in managing diabetes. Clinical guidelines emphasize the importance of these technologies in improving glycemic control and reducing complications. Despite limited data from randomized controlled trials, existing studies support the efficacy of CGM and CSII in various clinical scenarios, making them valuable tools in diabetes management.
Endocrine System on Chip for Diabetes Treatment
Innovative approaches like the "endocrine system on chip" are being developed to model diabetes and screen potential treatments. This microfluidic perfused 3D cell-culture chip co-cultures intestinal and pancreatic cells to measure insulin and GLP-1 release in response to glucose stimuli. This model has shown higher insulin production in response to glucose compared to traditional 2D cultures, suggesting its potential utility in drug screening and understanding dynamic endocrine responses.
Prevalence and Incidence of Endocrine and Metabolic Disorders
A comprehensive review of endocrine and metabolic disorders in the United States highlights the high prevalence of conditions like diabetes mellitus, obesity, and metabolic syndrome. These disorders often have significant public health implications, necessitating targeted research and resource allocation. The review also underscores the importance of understanding the epidemiology of these conditions to identify risk factors and improve prevention strategies.
Secondary Diabetes Mellitus and Endocrine Diseases
Secondary diabetes mellitus, often overlooked in literature, is associated with various endocrinopathies such as acromegaly, Cushing’s syndrome, and pheochromocytoma. These conditions impact β-cell function and insulin resistance through hormonal imbalances, increasing the risk of diabetes and its complications. Understanding these mechanisms is crucial for personalized therapeutic decisions and reducing cardiovascular risks in affected patients.
Advances in Pancreatic Endocrine Cell Production
The development of pancreatic endocrine cells from human embryonic stem cells (hES) represents a significant advancement in diabetes treatment. These cells can synthesize key pancreatic hormones and respond to secretory stimuli, although their glucose responsiveness is still limited. This technology holds promise for creating a renewable source of cells for diabetes cell therapy, potentially transforming treatment paradigms.
Conclusion
The interplay between endocrinology and diabetes is complex and multifaceted, involving environmental factors, technological advancements, and innovative research models. Understanding the role of EDCs, leveraging diabetes technology, and exploring new therapeutic avenues are critical steps in improving diabetes management and outcomes. Continued research and development in these areas will be essential for addressing the growing diabetes epidemic and enhancing patient care.
Sources and full results
Most relevant research papers on this topic
